Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Similar documents
ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Requirements. Effective: 05/01/2018

Step Therapy Requirements. Effective: 11/01/2018

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

FirstCarolinaCare Insurance Company. Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements

ANTICONVULSANTS. Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements. Effective: 03/01/2015

FirstCarolinaCare Insurance Company Step Therapy Requirements

2017 Step Therapy Criteria

ALLERGIC CONJUNCTIVITIS AGENTS

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

2018 Step Therapy Criteria

ALPHA GLUCOSIDASE INHIBITOR THERAPY

2018 Step Therapy Criteria (List of Step Therapy Criteria)

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Step Therapy Criteria 2019

2014 Step Therapy Criteria (List of Step Therapy Criteria)

ANTICONVULSANT STEP THERAPY

Step Therapy Medications

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ACYCLOVIR OINT (CCHP2017)

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

Step Therapy Group. Atypical Antipsychotic Agents

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

ANTICONVULSANT THERAPY

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

**CRITERIA UNDER CMS REVIEW**

2019 PDP Basic Step Therapy Document

Step Therapy Criteria

ATYPICAL ANTIPSYCHOTICS

CARE N CARE HEALTH PLAN

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

SelectHealth Advantage 2018 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

ADHD STIMULANTS-S(SHC)

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ACYCLOVIR OINT (CCHP2017)

2018 Step Therapy (ST) Criteria

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

ACYCLOVIR OINT (CCHP2017)

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

2018 Step Therapy FID 18088

ACYCLOVIR OINT (CCHP2017)

2018 Medicare Part D Formulary Change

2019 Simply Step Therapy Document

Step Therapy Group Algorithm Steps

Transcription:

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change at any time. You will receive notice when necessary. RMHP is a Medicare-approved Cost plan. Enrollment in RMHP depends on contract renewal. This information is available for free in other languages. Please call our Customer Service number at 888-282-1420 (TTY dial 711). Hours are 8am - 8pm, 7 days/week, Oct. 1 Feb.14, and 8am - 8pm, M-F, Feb.15 Sept.30. Esta información está disponible gratuitamente en otros idiomas. Por favor llame a la línea de Atención a Clientes, al 888-282-1420 (TTY marque 711). Horario de 8am - 8pm, 7 días a la semana, del 1 de octubre al 14 de febrero; y de 8am - 8pm, de lunes a viernes, del 15 de febrero al 30 de septiembre. NS_PH_PartDST_12012017 Updated December 2017

ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500 mg tablet Invokamet XR 150 mg-1,000 mg tablet, extended release Invokamet XR 150 mg-500 mg tablet, extended release Invokamet XR 50 mg-1,000 mg tablet, extended release Invokamet XR 50 mg-500 mg tablet, extended release Invokana 100 mg tablet Invokana 300 mg tablet Jardiance 10 mg tablet Jardiance 25 mg tablet Synjardy 12.5 mg-1,000 mg tablet Synjardy 12.5 mg-500 mg tablet Synjardy 5 mg-1,000 mg tablet Synjardy 5 mg-500 mg tablet Synjardy XR 10 mg-1,000 mg tablet, extended release Synjardy XR 12.5 mg-1,000 mg tablet, extended release Synjardy XR 25 mg-1,000 mg tablet, extended release Synjardy XR 5 mg-1,000 mg tablet, extended release PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE, TOLAZAMIDE, TOLBUTAMIDE), COMBINATION OF A SULFONYLUREA-METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE- METFORMIN OR PIOGLITAZONE- GLIMEPIRIDE WITHIN THE PAST 120 DAYS. 1

ANTI-INFLAMMATORY AGENTS - GI Dipentum 250 mg capsule PRIOR CLAIM FOR ANY 1 OF THE FOLLOWING: BALSALAZIDE, APRISO, DELZICOL, MESALAMINE DR 800 MG TAB, OR FORMULARY MESALAMINE 1.2 G DR TAB, WITHIN THE PAST 120 DAYS. 2

ANTIPSYCHOTIC AGENTS clozapine 100 mg disintegrating tablet clozapine 12.5 mg disintegrating tablet clozapine 150 mg disintegrating tablet clozapine 200 mg disintegrating tablet clozapine 25 mg disintegrating tablet Fanapt 1 mg tablet Fanapt 10 mg tablet Fanapt 12 mg tablet Fanapt 1mg(2)-2 mg(2)-4mg(2)-6 mg(2) tablets in a dose pack Fanapt 2 mg tablet Fanapt 4 mg tablet Fanapt 6 mg tablet Fanapt 8 mg tablet Saphris (black cherry) 10 mg sublingual tablet Saphris (black cherry) 2.5 mg sublingual tablet Saphris (black cherry) 5 mg sublingual tablet Versacloz 50 mg/ml oral suspension Vraylar 1.5 mg (1)-3 mg (6) capsules in a dose pack Vraylar 1.5 mg capsule Vraylar 3 mg capsule Vraylar 4.5 mg capsule Vraylar 6 mg capsule PRIOR CLAIM FOR FORMULARY VERSIONS OF ANY TWO ANTIPSYCHOTICS: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE, ARIPIPRAZOLE TABS/ODT WITHIN THE PAST 365 DAYS 3

ANTIPSYCHOTIC AGENTS II Rexulti 0.25 mg tablet Rexulti 0.5 mg tablet Rexulti 1 mg tablet Rexulti 2 mg tablet Rexulti 3 mg tablet Rexulti 4 mg tablet PRIOR CLAIM FOR TWO (2) FORMULARY VERSIONS OF ATYPICAL ANTIPSYCHOTICS (RISPERIDONE, CLOZAPINE, OLANZAPINE, QUETIAPINE FUMARATE, ARIPIPRAZOLE OR ZIPRASIDONE) OR A SSRI (CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE) OR SNRI (VENLAFAXINE OR DULOXETINE) WITHIN THE PAST 365 DAYS 4

ANTIULCER AGENTS Dexilant 30 mg capsule, delayed release Dexilant 60 mg capsule, delayed release PRIOR CLAIM FOR GENERIC FEDERAL LEGEND OMEPRAZOLE, PANTOPRAZOLE, OR LANSOPRAZOLE WITHIN THE PAST 120 DAYS. 5

B VERSUS D ADMINISTRATIVE STEP cyclophosphamide 25 mg capsule cyclophosphamide 50 mg capsule methotrexate sodium 2.5 mg tablet Trexall 10 mg tablet Trexall 15 mg tablet Trexall 5 mg tablet Trexall 7.5 mg tablet Xatmep 2.5 mg/ml oral solution IN ORDER TO ASSIST IN A PART B VS. D PAYMENT DETERMINATION, A PRIOR CLAIM SEEN FOR A RHEUMATOID ARTHRITIS, PSORIASIS OR ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS DRUG WITHIN THE PAST 120 DAYS WILL QUALIFY FOR PART D PAYMENT. ALL OTHER INDICATIONS WILL HAVE A PART B VS. D PAYMENT DETERMINATION MADE THROUGH THE FORMULARY EXCEPTION PROCESS PRIOR TO THE APPROVAL OF THE DRUG. 6

ELUXADOLINE Viberzi 100 mg tablet Viberzi 75 mg tablet PRIOR CLAIM FOR DICYCLOMINE AND XIFAXAN 550MG WITHIN THE PAST 120 DAYS. 7

GABAPENTIN SR Gralise 300 mg tablet,extended release Gralise 30-Day Starter Pack 300 mg (9)-600 mg (69) tablet,ext. release Gralise 600 mg tablet,extended release PRIOR CLAIM FOR GABAPENTIN IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 8

INSULIN/GLP-1 ANALOG Soliqua 100/33 100 unit-33 mcg/ml subcutaneous insulin pen Xultophy 100/3.6 100 unit-3.6 mg/ml (3 ml) subcutaneous insulin pen PRIOR CLAIM FOR 2 OF THE FOLLOWING (ONE FROM EACH GROUP): A) VICTOZA, TRULICITY, LANTUS, OR TOUJEO AND B) METFORMIN, METFORMIN ER, SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE), COMBO SULFONYLUREA- METFORMIN, PIOGLITAZONE, PIOGLITAZONE-METFORMIN, OR PIOGLITAZONE-GLIMEPIRIDE IN PAST 365 DAYS. 9

LESINURAD Zurampic 200 mg tablet PRIOR CLAIM FOR ULORIC OR ALLOPURINOL TABLETS WITHIN THE PAST 120 DAYS. 10

LISINOPRIL ORAL SOLUTION Qbrelis 1 mg/ml oral solution PRIOR CLAIM FOR GENERIC LISINOPRIL WITHIN THE PAST 120 DAYS. 11

METFORMIN ER metformin ER 1,000 mg tablet,extended release 24hr metformin ER 500 mg tablet,extended release 24hr PRIOR CLAIM FOR METFORMIN HCL ER TAB ER 24H (GENERIC GLUCOPHAGE XR) WITHIN THE PAST 120 DAYS. 12

NOVEL ORAL ANTICOAGULANTS Pradaxa 110 mg capsule Pradaxa 150 mg capsule Pradaxa 75 mg capsule PRIOR CLAIM FOR ELIQUIS AND XARELTO IN THE PAST 365 DAYS. 13

OPHTHALMIC ANTIHISTAMINES - NO OTC Alrex 0.2 % eye drops,suspension Bepreve 1.5 % eye drops PRIOR CLAIM FOR LEVOCETIRIZINE, CROMOLYN SODIUM, EPINASTINE, OR OLOPATADINE 0.1% EYE DROPS WITHIN THE PAST 120 DAYS 14

QUETIAPINE FUMARATE EXTENDED RELEASE quetiapine ER 150 mg tablet,extended release 24 hr quetiapine ER 200 mg tablet,extended release 24 hr quetiapine ER 300 mg tablet,extended release 24 hr quetiapine ER 400 mg tablet,extended release 24 hr quetiapine ER 50 mg tablet,extended release 24 hr PRIOR CLAIM FOR A FORMULARY VERSION OF ONE OF THE FOLLOWING: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE,CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, DULOXETINE, VENLAFAXINE, OR ARIPIPRAZOLE WITHIN THE PAST 365 DAYS. 15

RENIN ANGIOTENSIN SYSTEM INHIBITORS Edarbi 40 mg tablet Edarbi 80 mg tablet Edarbyclor 40 mg-12.5 mg tablet Edarbyclor 40 mg-25 mg tablet Tekamlo 150 mg-10 mg tablet Tekamlo 150 mg-5 mg tablet Tekamlo 300 mg-10 mg tablet Tekamlo 300 mg-5 mg tablet Tekturna 150 mg tablet Tekturna 300 mg tablet Tekturna HCT 150 mg-12.5 mg tablet Tekturna HCT 150 mg-25 mg tablet Tekturna HCT 300 mg-12.5 mg tablet Tekturna HCT 300 mg-25 mg tablet PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS. 16

SPRITAM Spritam 1,000 mg tablet for oral suspension Spritam 250 mg tablet for oral suspension Spritam 500 mg tablet for oral suspension Spritam 750 mg tablet for oral suspension PRIOR CLAIM FOR LEVETIRACETAM SOLUTION IN THE PAST 120 DAYS 17

ZARXIO Zarxio 300 mcg/0.5 ml injection syringe Zarxio 480 mcg/0.8 ml injection syringe MUST HAVE PREVIOUSLY TRIED NEUPOGEN PRIOR TO ZARXIO 18

INDEX Alrex 0.2 % eye drops,suspension... 14 Bepreve 1.5 % eye drops...14 clozapine 100 mg disintegrating tablet... 3 clozapine 12.5 mg disintegrating tablet... 3 clozapine 150 mg disintegrating tablet... 3 clozapine 200 mg disintegrating tablet... 3 clozapine 25 mg disintegrating tablet...3 cyclophosphamide 25 mg capsule... 6 cyclophosphamide 50 mg capsule... 6 Dexilant 30 mg capsule, delayed release...5 Dexilant 60 mg capsule, delayed release...5 Dipentum 250 mg capsule...2 Edarbi 40 mg tablet...16 Edarbi 80 mg tablet...16 Edarbyclor 40 mg-12.5 mg tablet... 16 Edarbyclor 40 mg-25 mg tablet...16 Fanapt 1 mg tablet...3 Fanapt 10 mg tablet...3 Fanapt 12 mg tablet...3 Fanapt 1mg(2)-2 mg(2)-4mg(2)-6 mg(2) tablets in a dose pack...3 Fanapt 2 mg tablet...3 Fanapt 4 mg tablet...3 Fanapt 6 mg tablet...3 Fanapt 8 mg tablet...3 Glyxambi 10 mg-5 mg tablet...1 Glyxambi 25 mg-5 mg tablet...1 Gralise 300 mg tablet,extended release... 8 Gralise 30-Day Starter Pack 300 mg (9)- 600 mg (69) tablet,ext. release... 8 Gralise 600 mg tablet,extended release... 8 Invokamet 150 mg-1,000 mg tablet...1 Invokamet 150 mg-500 mg tablet...1 Invokamet 50 mg-1,000 mg tablet...1 Invokamet 50 mg-500 mg tablet... 1 Invokamet XR 150 mg-1,000 mg tablet, extended release... 1 Invokamet XR 150 mg-500 mg tablet, extended release... 1 Invokamet XR 50 mg-1,000 mg tablet, extended release... 1 Invokamet XR 50 mg-500 mg tablet, extended release... 1 Invokana 100 mg tablet... 1 Invokana 300 mg tablet... 1 Jardiance 10 mg tablet... 1 Jardiance 25 mg tablet... 1 metformin ER 1,000 mg tablet,extended release 24hr... 12 metformin ER 500 mg tablet,extended release 24hr... 12 methotrexate sodium 2.5 mg tablet...6 Pradaxa 110 mg capsule...13 Pradaxa 150 mg capsule...13 Pradaxa 75 mg capsule...13 Qbrelis 1 mg/ml oral solution... 11 quetiapine ER 150 mg tablet,extended release 24 hr... 15 quetiapine ER 200 mg tablet,extended release 24 hr... 15 quetiapine ER 300 mg tablet,extended release 24 hr... 15 quetiapine ER 400 mg tablet,extended release 24 hr... 15 quetiapine ER 50 mg tablet,extended release 24 hr... 15 Rexulti 0.25 mg tablet...4 Rexulti 0.5 mg tablet...4 Rexulti 1 mg tablet... 4 Rexulti 2 mg tablet... 4 Rexulti 3 mg tablet... 4 Rexulti 4 mg tablet... 4 Saphris (black cherry) 10 mg sublingual tablet...3 Saphris (black cherry) 2.5 mg sublingual tablet...3 Saphris (black cherry) 5 mg sublingual tablet...3 Soliqua 100/33 100 unit-33 mcg/ml subcutaneous insulin pen... 9 Spritam 1,000 mg tablet for oral suspension...17 Spritam 250 mg tablet for oral suspension...17 Spritam 500 mg tablet for oral suspension...17 Spritam 750 mg tablet for oral suspension...17 19

Synjardy 12.5 mg-1,000 mg tablet...1 Synjardy 12.5 mg-500 mg tablet...1 Synjardy 5 mg-1,000 mg tablet...1 Synjardy 5 mg-500 mg tablet... 1 Synjardy XR 10 mg-1,000 mg tablet, extended release... 1 Synjardy XR 12.5 mg-1,000 mg tablet, extended release... 1 Synjardy XR 25 mg-1,000 mg tablet, extended release... 1 Synjardy XR 5 mg-1,000 mg tablet, extended release... 1 Tekamlo 150 mg-10 mg tablet...16 Tekamlo 150 mg-5 mg tablet...16 Tekamlo 300 mg-10 mg tablet...16 Tekamlo 300 mg-5 mg tablet...16 Tekturna 150 mg tablet...16 Tekturna 300 mg tablet...16 Tekturna HCT 150 mg-12.5 mg tablet... 16 Tekturna HCT 150 mg-25 mg tablet... 16 Tekturna HCT 300 mg-12.5 mg tablet... 16 Tekturna HCT 300 mg-25 mg tablet... 16 Trexall 10 mg tablet... 6 Trexall 15 mg tablet... 6 Trexall 5 mg tablet...6 Trexall 7.5 mg tablet... 6 Versacloz 50 mg/ml oral suspension... 3 Viberzi 100 mg tablet... 7 Viberzi 75 mg tablet...7 Vraylar 1.5 mg (1)-3 mg (6) capsules in a dose pack...3 Vraylar 1.5 mg capsule...3 Vraylar 3 mg capsule... 3 Vraylar 4.5 mg capsule...3 Vraylar 6 mg capsule... 3 Xatmep 2.5 mg/ml oral solution...6 Xultophy 100/3.6 100 unit-3.6 mg/ml (3 ml) subcutaneous insulin pen... 9 Zarxio 300 mcg/0.5 ml injection syringe. 18 Zarxio 480 mcg/0.8 ml injection syringe. 18 Zurampic 200 mg tablet... 10 20